Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Yaounde Central Hospital
Aim: to determine and compare the short term effect of angiotensin converting in the management of hypertension as well as the oxidative effect of Zofenopril and perindopril in blacks hypertensive patients in the Yaoundé Central Hospital.
Method: A double-arm, double-blind, randomized and parallel clinical trial conducted at the Yaoundé Central Hospital. Hypertensive patients who are not taking angiotensin-converting enzyme inhibitor or angiotensin receptors blockers, are randomize into 2 groups. Depending on the group, the intervention consisted of the administration of Perindopril 10 mg daily or Zofenopril 30 mg daily for 08 weeks. The endpoints were the nycthemeral blood pressure profile, pro oxidant marker (malondialdehyde) and anti-oxidant marker (Ferric reducing antioxidant).
Progress: Recruitment for PEZO-HP was completed in May 2019 with 24 patients.
Age
21–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Hypertensive patients
On a stable atihypertensive therapies (determined by the investigator) for at least 3 months with no classes changes. The pharmacological treatment should not include an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker
Subject must not present any contraindication to exercise
Before any study-specific procedure, the appropriate written informed consent must be obtained.
You may not be if
Side effects affecting life quality of patients (determined by the Data Safety Monitoring Board).